Issue link: http://www.e-digitaleditions.com/i/932381
Inhalation FEBRUARY 2018 15 45. Le Guellec S, Le Pennec D, Durand M, Pourchez J, Jamar F, Chantrel G and Vecellio L. In vivo/in vitro compari- son of aerosol nasal deposition. J Aerosol Med Pulm Drug Deliv. 2013; 26: A23-A24. 46. Shah SA, Berger RL, McDermott J, Gupta P, Monteith D, Connor A and Lin W. Regional deposition of mometa- sone furoate nasal spray suspension in humans. Allergy Asthma Proc. 2014;36:48- 57. 47. Leach CL, Kuehl PJ, Chand R and McDonald JD. Nasal deposition of HFA-beclomethasone, aqueous uticasone propionate and aqueous mometasone furoate in allergic rhi- n i t i s p a t i e n t s . J A e r o s o l Me d Pu l m Dr u g D e l i v. 2015;28(5):334-340. Mandana Azimi, PhD is a postdoctoral fellow at GSK Consumer Healthcare, Warren, NJ, US. Gerallt Wil- liams, PhD is the Director of Scienti c A airs, Aptar Pharma. Laleh Golshahi, PhD is an Assistant Professor and P. Worth Longest, PhD is a Professor in the Depart- ment of Mechanical and Nuclear Engineering at Vir- ginia Commonwealth University. Michael Hindle, PhD is the Peter R. Byron Distinguished Professor in the Department of Pharmaceutics, Virginia Commonwealth University. Corresponding author: Michael Hindle, PhD, Box 980533, Department of Pharmaceutics, Vir- ginia Commonwealth University, Richmond, VA, 23298, US. Tel: 804 828-6497, mhindle@vcu.edu. Website: https://wp.vcu.edu/mhindle/mhindle. 38. Azimi M, Darweesh R, Hindle M, Farkas DR, Golshahi L, Sakagami M and Longest PW. e use of a physically real- istic nasal airway model for the assessment of in vitro transep- ithelial transport of nasally administered drugs. J Aerosol Med Pulm Drug Deliv. 2017;30(3):A19. 39. Schroeter JD, Tewksbury EW, Wong BA and Kimbell JS. Experimental measurements and computational predictions of regional particle deposition in a sectional nasal model. J Aerosol Med Pulm Drug Deliv. 2015;28:20-29. 40. Kundoor V and Dalby RN. Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method. Pharm Res. 2010;27:30-36. 41. Rygg A, Hindle M and Longest PW. Linking suspension nasal spray drug deposition patterns to pharmacokinetic pro les: A proof-of-concept study using computational uid dynamics. J Pharm Sci. 2016;105:1995-2004. 42. Kimbell J, Segal RA, Asgharian B, Wong BA, Schroeter JD, Southall JP, Dickens CJ, Brace G and Miller FJ. Charac- terization of deposition from nasal spray devices using a computational uid dynamics model of the human nasal passages. J Aerosol Med. 2007;20:59-74. 43. Guo Y, Laube B and Dalby RN. e e ect of formula- tion variables and breathing patterns on the site of nasal deposition in an anatomically correct model. Pharm Res. 2005;22:1871-1878. 44. Durand M, Pourchez J, Aubert G, Le Guellec S, Navarro L, Forest V, Rusch P and Cottier M. Impact of acoustic air ow nebulization on intrasinus drug deposition of a human plastinated nasal cast: New insights into the mechanisms involved. Int J Pharm. 2011;421:63-71. Nasal Drug Delivery Now in its 16th year 12-13 April 2018, The Rembrandt Hotel, London Three reasons to attend 1. Gain an update on the very latest scientific developments and technology advances in this field. 2. Hear from an unrivalled panel of expert speakers. 3. An excellent networking opportunity to build business relationships. 3 easy ways to book management-forum.co.uk +44 (0)20 7749 4730 info@management-forum.co.uk Exhibition opportunities are available! For more information contact Customer Services on +44 (0)20 7749 4730 or email: info@management-forum.co.uk SAVE £200/€280 when using promotional code NDDIHL18 when registering online An essential update on the latest scientific developments, technology advances and regulatory guidance